Though research suggests a first-born child has bragging rights for better education, the flip side may be increased chances of myopia, according to a new study.
Up to 1 billion people at risk of blindness by 2050
Up to 1 billion people could be at risk of blindness by the middle of the century if an emerging short-sightedness (myopia) epidemic is ignored say researchers at the Brien Holden Vision Institute.
RightEye Neuro Vision Concussion Test Unveiled at American Academy of Optometry Show
NEW ORLEANS & WASHINGTON–(BUSINESS WIRE)–RightEye LLC, a health technology company using eye tracking to revolutionize vision performance and patient care, today announced at the 2015 American Academy of Optometry show in New Orleans the launch of RightEye Neuro Vision — a new 15-second concussion test that helps health care providers more clearly understand the severity of a patient’s head trauma and better assess their recovery over time. “It’s common for concussion patients to be in denial
Up to 1 billion people could be at risk of going blind by 2050, say researchers
Up to 1 billion people could be at risk of blindness by the middle of the century if an emerging short-sightedness (myopia) epidemic is ignored say researchers at the Brien Holden Vision Institute.
Publication Exclusive: Now is the time to prepare for possible introduction of lifitegrast
Summer is over, even for empty nesters like yours truly. It is “back to school” for all of us in the office, too, as many of us enter our busy seasons. Along with the usual sense of excitement in the air that comes with cooler nights and the sights and sounds of activity on the gridiron, we are on the edge of an exciting new age in the treatment of dry eye. Or maybe not. Or only sort of. I am talking, of course, of the impending FDA decision due on the filing of Shire’s new drug application for lifitegrast, a new medicine for the treatment of dry eye.The only thing of which we can be certain is that you will soon become familiar with the heretofore forgotten term “dysgeusia.”
OneSight and Deloitte Announce Startling Finding: 1.1 Billion People Need Glasses, but Lack Access
CINCINNATI–(BUSINESS WIRE)–OneSight, an independent nonprofit committed to eradicating the global vision care crisis, today announced the findings from The Global Need for Glasses Study, conducted in collaboration with Deloitte